Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Rln3 ELISA Kit (AC3022)
Cat.#: ASET-1611
Specifications
Description Mouse Rln3 ELISA Kit allows for the in vitro quantitative determination of mouse Rln3 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.938 mIU/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.563-100 mIU/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2372 Human GABA A Receptor alpha 1 ELISA Kit (AC3783) Quantitative inquiry ASET-1082 Mouse Granulin ELISA Kit (AC2493) Quantitative inquiry ASET-1208 Mouse Adiponectin ELISA Kit (AC2619) Quantitative inquiry ASET-1759 Human FGFR1 ELISA Kit (AC3170) Quantitative inquiry ASET-2253 Mouse Fat3 ELISA Kit (AC3664) Quantitative inquiry ASET-1238 Human HCN4 ELISA Kit (AC2649) Quantitative inquiry ASET-2348 Rat BDNF ELISA Kit (AC3759) Quantitative inquiry ASET-2329 Mouse Galectin 3 ELISA Kit (AC3740) Quantitative inquiry ASET-1169 Human CELSR2 ELISA Kit (AC2580) Quantitative inquiry ASET-1715 Mouse CaMKII beta ELISA Kit (AC3126) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket